Capital Rx Insights (February 2024)
Mark your calendar! On March 21, Capital Rx’s Bridget Mulvenna , Vice President of Business Development, will share her insights and experience to help everyone level up their pharmacy benefit manager (PBM) procurement processes! Before joining Capital Rx in late 2023, Bridget was the Director of Pharmacy Programs at Erickson Senior Living, where she saved the company millions upon millions of dollars over ~9 years, first on their long-term care side of the business, then on pharmacy benefit program spend.
You won’t want to miss this, as Bridget will walk through (at least) five practical ways to improve your PBM procurement process.
Read on for the usual roundup of news and insights from the Capital Rx team, and CLICK HERE to RSVP!
Related Content
?? Benefits Pro: 5 ways to improve your PBM procurement process in 2024?
Astonishing Healthcare
If you haven’t yet, visit our Astonishing Healthcare Podcast page or subscribe on Apple or Spotify!?
Capital Rx’s enterprise health platform, JUDI? , combines all the pharmacy benefit-related administrative workflows into one intuitive, highly efficient, open platform.?
Click here to download our whitepaper: The Upside of Modern Technology vs. Legacy Claims Processing Systems!
Knowledge Exchange?
What does New York City FC and Capital Rx Announce Sleeve Partnership mean for the local NYC community? Well, that depends. If you’ve got an MLS team in your area, be on the lookout for the Capital Rx team and any events. We’re working in concert with a like-minded partner to raise awareness of our brand on a national scale and in the local NYC community.
In How Our Favorite New JUDI? Features Aid Pharmacy Benefit Administration, we highlight 9 of our favorite features of JUDI and their capabilities. Karen Dierker , Capital Rx’s Senior Vice President of Product Management, explains how these features, in their own ways, help users increase their operational efficiency at a lower cost.?
领英推荐
Drug Pipeline & Clinical Update - January 2024: The Capital Rx Clinical Team highlighted one new approval - Zelsuvmi? topical gel - three new notable expanded indications, one biosimilar approval (Udenyca Onbody?), and one notable generic launch (Prolensa?) to start 2024.?
Consultant Corner: What Matters Most?
Channel Partners,? ?
To follow up on my episode of The Astonishing Healthcare Podcast, it’s worth emphasizing three key things:?
It’s time to demand more! After all, your plans are paying the PBM to MANAGE their pharmacy spend.
Brian TenEyck , Director, Consultant Relations || [email protected]
Most Read News at Capital Rx
We're Hiring!
If you are looking, or know anyone looking, for a new role in the PBM industry, please click below to visit our careers page.
We hope you’re enjoying this newsletter. We welcome your feedback, questions, and suggestions for future content. And if you’d like to discuss how Capital Rx drives Validated Savings for payers. We’d love to hear from you!
Visit Capital Rx Insights to access the content herein and much, much more. And don't forget to follow us on LinkedIn so you never miss an update.
Thank you for reading, and have a great rest of your day!